Reference Medicine was founded in June 2021 by a group of oncology researchers who were frustrated that their lab work would constantly get delayed waiting on specimens. These specimens are hard to find, complicated to source, often poor quality, and expensive. Meanwhile, cancer patients globally want to help by providing samples from their surgeries. By connecting with the patient community and utilizing their decades of specimen preservation experience, Reference Medicine is able to offer a comprehensive product line of specimens that are tailor-made for oncology test developers at a fraction of the cost - giving patients meaning to their disease and helping biotech teams spend less time sourcing and more time building the next life-saving diagnostic. read more